Another potential receptor that may explain the association between COVID-19 and diabetes involves the dipeptidyl peptidase-4 (DPP4 or CD26) enzyme (Figure 3E), which is widely expressed in many tissues (such as kidneys, lungs, intestines and immune cells) and plays a key role in inflammation as well as glucose homeostasis. Here, DPP4 is linked to COVID-19.